David Valcárcel-Ferreiras

18PUBLICATIONS

126CO-AUTHORS

Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyGene mappingHaematology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Jun 29, 2026

Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|May 30, 2026

Switching patients with immune thrombocytopenia (ITP) to avatrombopag from other thrombopoietin receptor agonists: The real-world experience of the Spanish ITP Group (GEPTI).

|Apr 30, 2026

How should myelodysplastic neoplasms with isolated deletion 5q and TP53 multihit alterations be classified?

|Apr 09, 2026

Performance and clinical utility of Spanish germ line genetic testing criteria for hematologic neoplasms predisposition.

Sara Torres-Esquius, Guillermo Ramil, Maria Gabarrós-Subirà

|Mar 28, 2026

Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia.

María-Eva Mingot-Castellano, María Teresa Álvarez Román, Jose María Bastida

|Mar 21, 2026

Real-World Safety and Efficacy of Avatrombopag in Adults with Immune Thrombocytopenia: A Systematic Review and Meta-Analysis.

M L Lozano, D Valcarcel

Pageof 3

Frequent Collaborators

Francesc Bosch

Blanca Xicoy

Claudia Haferlach

Valeria Santini

Laura Palomo

Francesc Solé

María Díez-Campelo

Irene García-Cadenas

Guillermo Garcia-Manero

2 joint publications

Pere Barba

Frequent Collaborators

Francesc Bosch

Blanca Xicoy

Claudia Haferlach

Valeria Santini